ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Cap-Drop: A Pre-Programmed, Self-Powered Capillary Microfluidic System for Passive Droplet Generation and 3D Cell Culture Modeling.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- 3D bioprinting of microfluidic systems for cardiac regenerative medicine: from biofabrication to organ-on-a-chip.Journal of biological engineering · 2026Review
- Integrated Microfluidic Chip Enabling Preparation and Immobilization of Cell-Laden Microspheres, and Microsphere-Based Cell Culture and Analysis.Biosensors · 2026Article
- Artificial Intelligence-Aided Microfluidic Cell Culture Systems.Biosensors · 2025Review
- Cap-Drop: A Pre-Programmed, Self-Powered Capillary Microfluidic System for Passive Droplet Generation and 3D Cell Culture Modeling.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
3D cell culture models and precision diagnostics have advanced significantly through microfluidic systems, yet their broad implementation remains limited by challenges in scalability, integration, and portability. Effective 3D cell culture models require systems that maintain sample integrity, minimize evaporation, and avoid crosstalk while handling various biofluids. However, current platforms often depend on active pumping, bulky components, and complex controls, which hinder portability, usability, and affordability. To address these challenges, the Capillary Droplet microfluidic (Cap-Drop) is presented, a novel capillary-driven platform that generates and immobilizes droplets with precision, eliminating the need for external pumps or intricate setups. Unlike conventional system, where moving droplets complicate tracking and identification, Cap-Drop ensures fixed droplet positioning, allowing seamless tracking and analysis. By integrating hydrophilic and hydrophobic materials with several innovative capillary elements -including passive vents (PV), pressure reducer (PR), stop valves (SV), delay channels, and bubble trap (BT)-Cap-Drop enables robust droplet formation (40 to 500 nL) for biofluids of varying properties. The pre-programmed design of PV in corporation with other capillary elements autonomously seals microwells (MWs), ensuring consistent sample digitization and supress risk of evaporation. Cap-Drop is optimized and offers a transformative platform for microfluidic technologies in mechanistic cellular studies, preclinical drug screening, and clinical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.